Drugs for hepatitis C: unlocking a new mechanism of action.
Bell
Thomas W
TW
Department of Chemistry, University of Nevada, Reno, NV 89557-0216, USA. twb@unr.edu
D000998:Antiviral Agents / Q000737:chemistry* / Q000494:pharmacology; D002986:Clinical Trials as Topic; D004791:Enzyme Inhibitors / Q000737:chemistry* / Q000494:pharmacology; D005838:Genotype; D006526:Hepatitis C / Q000188:drug therapy*; D006801:Humans; D017361:Viral Nonstructural Proteins / Q000037:antagonists & inhibitors / Q000378:metabolism; D012324:RNA-Dependent RNA Polymerase
D000998:Antiviral Agents; D004791:Enzyme Inhibitors; D017361:Viral Nonstructural Proteins; C087036:NS-5 protein, hepatitis C virus; D012324:RNA-Dependent RNA Polymerase